MEDICENNA UPDATES MDNA11 CLINICAL TRIAL RESULTS AT THE ESMO-IO CONGRESS 2025, FURTHER BOLSTERING ITS ANTI-TUMOR ACTIVITY IN ADVANCED SOLID TUMORS

Reuters · 2d ago

Please log in to view news